Literature DB >> 26623055

Comparison of semi-extended and standard lymph node dissection in radical prostatectomy: A single-institute experience.

Senji Hoshi1, Natuho Hayashi2, Yuuta Kurota2, Kiyotsugu Hoshi3, Akinori Muto2, Osamu Sugano2, Kenji Numahata2, Vladimir Bilim4, Isoji Sasagawa3, Shoichiro Ohta5.   

Abstract

Standard lymphadenectomy for prostate cancer is limited to the obturator lymph nodes (LNs), although the internal and external iliac LNs represent the primary landing zone for prostatic lymphatic drainage. We performed anatomically semi-extended pelvic lymph node dissection (PLND) to assess the incidence of LN metastasis in cases of clinically localized prostate cancer. A total of 730 consecutive patients underwent radical prostatectomy with either semi-extended PLND, comprising 6 selective fields, namely the external iliac, internal iliac and obturator LNs bilaterally, or standard LND (obturator LNs alone). A total of 131 patients undergoing semi-extended PLND were compared with 599 patients undergoing standard LND. The patients were stratified into high-risk [prostate-specific antigen (PSA)>20 ng/ml, Gleason score (GS)≥8], intermediate-risk (PSA 10-20 ng/ml, GS=4+3) and low-risk (PSA<10 ng/ml, GS≤3+4) subgroups. Following semi-extended LND, positive LNs were detected in 12/61 (20%) of the high-risk, 1/30 (3%) of the intermediate-risk and 0/40 (0%) of the low-risk cases. Following standard LND, positive LNs were detected in 13/182 (7%) of the high-risk, 1/164 (0.6%) of the intermediate-risk and 0/253 (0%) of the low-risk cases. In high-risk patients, the detection rate of LN metastasis was significantly higher following extended LND compared with standard LND (P<0.01). In 9 of 13 patients (69%), metastases were identified in the internal and external iliac regions, despite negative obturator LNs. There were no significant differences regarding intraoperative and postoperative complications or blood loss in the two groups. There was no lymphocele formation in patients undergoing either standard or semi-extended LND. Extended pelvic LND (PLND) is associated with a high rate of LN metastasis detection outside the fields of standard LND in cases with clinically localized prostate cancer. Therefore, LND including the internal and external iliac LNs should be performed in all patients with high-risk prostate cancer; however, in the low-risk group, PLND may be omitted.

Entities:  

Keywords:  radical prostatectomy; semi-extended lymph node dissection; standard lymph node dissection

Year:  2015        PMID: 26623055      PMCID: PMC4535077          DOI: 10.3892/mco.2015.601

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  14 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Development of "extended radical retropubic prostatectomy": a surgical technique for improving margin positive rates in prostate cancer.

Authors:  H Miyake; H Fujimoto; M Komiyama; M Fujisawa
Journal:  Eur J Surg Oncol       Date:  2009-11-07       Impact factor: 4.424

Review 3.  EAU guidelines on prostate cancer.

Authors:  Axel Heidenreich; Gunnar Aus; Michel Bolla; Steven Joniau; Vsevolod B Matveev; Hans Peter Schmid; Filliberto Zattoni
Journal:  Eur Urol       Date:  2007-09-19       Impact factor: 20.096

4.  Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.

Authors:  Darko Kroepfl; Heinrich Loewen; Ulla Roggenbuck; Michael Musch; Virgilius Klevecka
Journal:  BJU Int       Date:  2006-05       Impact factor: 5.588

5.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Authors:  Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

6.  Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.

Authors:  K Weingärtner; A Ramaswamy; A Bittinger; E W Gerharz; D Vöge; H Riedmiller
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

7.  Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987.

Authors:  G D Steinberg; J I Epstein; S Piantadosi; P C Walsh
Journal:  J Urol       Date:  1990-12       Impact factor: 7.450

8.  Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.

Authors:  H Zincke
Journal:  Urology       Date:  1989-05       Impact factor: 2.649

9.  Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy.

Authors:  Martin C Schumacher; Fiona C Burkhard; George N Thalmann; Achim Fleischmann; Urs E Studer
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

10.  Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.

Authors:  W J Catalona; D S Smith
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

View more
  5 in total

Review 1.  Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer.

Authors:  Michele Colicchia; Vidit Sharma; Firas Abdollah; Alberto Briganti; R Jeffrey Karnes
Journal:  Curr Urol Rep       Date:  2017-07       Impact factor: 3.092

2.  Establishment and validation of a novel predictive model to quantify the risk of bone metastasis in patients with prostate cancer.

Authors:  Yu-Jie Lu; Wei-Ming Duan
Journal:  Transl Androl Urol       Date:  2021-01

Review 3.  THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS.

Authors:  Dean Markić; Romano Oguić; Kristian Krpina; Ivan Vukelić; Gordana Đorđević; Iva Žuža; Josip Španjol
Journal:  Acta Clin Croat       Date:  2019-11       Impact factor: 0.780

Review 4.  Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Jakub Karwacki; Róża Czerwińska; Paulina Długosz; Artur Lemiński; Łukasz Nowak; Wojciech Krajewski; Tomasz Szydełko
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

5.  Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold.

Authors:  Zilvinas Venclovas; Tim Muilwijk; Aivaras J Matjosaitis; Mindaugas Jievaltas; Steven Joniau; Daimantas Milonas
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.